Combination therapy cuts death Risk in advanced prostate cancer: PEACE-3 trial
PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
The recommendation is based on new data from continuous safety monitoring of medicines in the EU
Semaglutide—a glucagon?like peptide?1 receptor agonist (GLP-1RA) sold as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management and cardiovascular risk reduction
The study evaluated patients with stage III/IV melanoma after complete tumor resection
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
This Breakthrough Therapy Designation highlights the impressive clinical benefit of Enhertu over the current standard of care
Updated results from the EMBER-3 study showed that the drug -- Inluriyo (imlunestrant) -- as a standalone treatment cut the risk of progression or death by 38%
The company has unveiled the results of pirtobrutinib from its BRUIN CLL-313 study
INEOS production of BDO in Germany, which produces a vital ingredient for antibiotics, statins and vitamin B6, is being crushed by a flood of carbon heavy imports and product dumping from the Far East
Subscribe To Our Newsletter & Stay Updated